The Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP) presents the evolution of the PCCTC, abiraterone, and enzalutamide.
Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.